Levocetirizina Krka (Levocetirizine Dihydrochloride)

Levocetirizine acts as a selective peripheral H1‑receptor antagonist. By binding to H1 receptors on mast cells and other tissues, it blocks histamine from triggering the cascade that causes vasodilation, increased permeability, and nerve irritation, thereby diminishing the typical signs of an allergic reaction.

The appropriate dose of Levocetirizina Krka is determined by the prescribing healthcare professional based on the patient’s age, renal function, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for levocetirizine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is a second‑generation antihistamine that offers effective symptom control with a lower incidence of sedation compared with first‑generation agents. Compared with other second‑generation drugs, it provides rapid onset and consistent efficacy, though individual response may vary.

Store Levocetirizina Krka at ambient temperature below 25 °C, in the original packaging, and protect it from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s potency and stability throughout its shelf life.

Levocetirizina Krka is taken orally, usually with or without food, as a single tablet per day. The exact timing and whether it should be taken with meals are determined by the prescribing clinician based on patient preference and tolerability.

The most serious risks, though rare, include anaphylactic reactions and severe skin disorders such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience symptoms like widespread rash, blistering, or difficulty breathing.

Levocetirizina Krka is contraindicated in individuals with known hypersensitivity to levocetirizine or any excipients in the tablet. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those taking interacting medications listed under major interactions.